[HTML][HTML] Establishing optimal quantitative-polymerase chain reaction assays for routine diagnosis and tracking of minimal residual disease in JAK2-V617F-associated …
Leukemia, 2013 - nature.com
Reliable detection of JAK2-V617F is critical for accurate diagnosis of myeloproliferative
neoplasms (MPNs); in addition, sensitive mutation-specific assays can be applied to monitor …
neoplasms (MPNs); in addition, sensitive mutation-specific assays can be applied to monitor …
[PDF][PDF] Establishing optimal quantitative-polymerase chain reaction assays for routine diagnosis and tracking of minimal residual disease in JAK2-V617F-associated …
JV Jovanovic, A Ivey, AM Vannucchi, E Lippert… - …, 2013 - pureadmin.qub.ac.uk
The discovery of the JAK2-V617F mutation in 2005 transformed the diagnostic work-up of
myeloproliferative neoplasms (MPNs), which occurs in B98% of polycythemia vera (PV) …
myeloproliferative neoplasms (MPNs), which occurs in B98% of polycythemia vera (PV) …
Establishing optimal quantitative-polymerase chain reaction assays for routine diagnosis and tracking of minimal residual disease in JAK2-V617F-associated …
JV Jovanovic, A Ivey, AM Vannucchi, E Lippert… - …, 2013 - pubmed.ncbi.nlm.nih.gov
Reliable detection of JAK2-V617F is critical for accurate diagnosis of myeloproliferative
neoplasms (MPNs); in addition, sensitive mutation-specific assays can be applied to monitor …
neoplasms (MPNs); in addition, sensitive mutation-specific assays can be applied to monitor …
[PDF][PDF] Establishing optimal quantitative-polymerase chain reaction assays for routine diagnosis and tracking of minimal residual disease in JAK2-V617F-associated …
JV Jovanovic, A Ivey, AM Vannucchi, E Lippert… - Leukemia, 2013 - boris.unibe.ch
Reliable detection of JAK2-V617F is critical for accurate diagnosis of myeloproliferative
neoplasms (MPNs); in addition, sensitive mutation-specific assays can be applied to monitor …
neoplasms (MPNs); in addition, sensitive mutation-specific assays can be applied to monitor …
[PDF][PDF] Establishing optimal quantitative-polymerase chain reaction assays for routine diagnosis and tracking of minimal residual disease in JAK2-V617F-associated …
JV Jovanovic, A Ivey, AM Vannucchi, E Lippert… - Leukemia, 2013 - pure.qub.ac.uk
The discovery of the JAK2-V617F mutation in 2005 transformed the diagnostic work-up of
myeloproliferative neoplasms (MPNs), which occurs in B98% of polycythemia vera (PV) …
myeloproliferative neoplasms (MPNs), which occurs in B98% of polycythemia vera (PV) …
[PDF][PDF] Establishing optimal quantitative-polymerase chain reaction assays for routine diagnosis and tracking of minimal residual disease in JAK2-V617F-associated …
JV Jovanovic, A Ivey, AM Vannucchi, E Lippert… - Leukemia, 2013 - scienceopen.com
The discovery of the JAK2-V617F mutation in 2005 transformed the diagnostic work-up of
myeloproliferative neoplasms (MPNs), which occurs in B98% of polycythemia vera (PV) …
myeloproliferative neoplasms (MPNs), which occurs in B98% of polycythemia vera (PV) …
[引用][C] Establishing optimal quantitative-polymerase chain reaction assays for routine diagnosis and tracking of minimal residual disease in JAK2-V617F-associated …
JV Jovanovic, A Ivey, AM Vannucchi, E Lippert… - Leukemia, 2013 - sonar.ch
Establishing optimal quantitative-polymerase chain reaction assays for routine diagnosis and
tracking of minimal residual disease in JAK2-V617F-associated myeloproliferative neoplasms …
tracking of minimal residual disease in JAK2-V617F-associated myeloproliferative neoplasms …
Establishing optimal quantitative-polymerase chain reaction assays for routine diagnosis and tracking of minimal residual disease in JAK2-V617F-associated …
J Jovanovic, A Ivey, A Vannucchi, E Lippert… - LEUKEMIA, 2013 - flore.unifi.it
Establishing optimal quantitative-polymerase chain reaction assays for routine diagnosis
and tracking of minimal residual disease in JAK2-V617F-associated myeloproliferative …
and tracking of minimal residual disease in JAK2-V617F-associated myeloproliferative …
Establishing optimal quantitative-polymerase chain reaction assays for routine diagnosis and tracking of minimal residual disease in JAK2-V617F-associated …
JV Jovanovic, A Ivey, AM Vannucchi, E Lippert… - Leukemia, 2013 - forskning.ruc.dk
Reliable detection of JAK2-V617F is critical for accurate diagnosis of myeloproliferative
neoplasms (MPNs); in addition, sensitive mutation-specific assays can be applied to monitor …
neoplasms (MPNs); in addition, sensitive mutation-specific assays can be applied to monitor …
[引用][C] Establishing optimal quantitative-polymerase chain reaction assays for routine diagnosis and tracking of minimal residual disease in JAK2-V617F-associated …
JV Jovanovic, A Ivey, AM Vannucchi, E Lippert… - Leukemia, 2013 - cir.nii.ac.jp
Establishing optimal quantitative-polymerase chain reaction assays for routine diagnosis
and tracking of minimal residual disease in JAK2-V617F-associated myeloproliferative …
and tracking of minimal residual disease in JAK2-V617F-associated myeloproliferative …